<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><atom:link href="https://rsseverything.com/feed/5a44e712-2dce-412c-8683-f6fa58f0280c.xml" rel="self" type="application/rss+xml"></atom:link><title>é«˜å½±å“åŠ›ç ”ç©¶-ç”Ÿç‰©ç»Ÿè®¡å­¦</title><link/>https://academic.oup.com/biostatistics/pages/highly_cited_articles <description><![CDATA[Explore a collection of the most read andÂ most cited articles making an impact inÂ BiostatisticsÂ published within the past two years.]]></description><lastbuilddate> 2023 å¹´ 12 æœˆ 30 æ—¥æ˜ŸæœŸå…­ 22:13:56 +0000</lastbuilddate><generator> RSS ä¸€åˆ‡</generator><ttl>360</ttl><item><guid ispermalink="false"> 6a06e64acc73ae5e6ca22115b4bad395</guid><pubDate> Wed, 18 Oct 2023 01:12:04 +0000</pubDate><title></title><link/> #skipNav&quot; class=&quot;skipnav <description><![CDATA[Cluster randomized trials often exhibit a three-level structure with participants nested in subclusters such as health care providers, and subclusters nested in clusters such as clinics. While the average treatment effect has been the primary focus in planning three-level randomized trials, interest is growing in ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> 156fa563237a4ce8e270d2668c927b48</guid><pubDate> Sun, 19 Nov 2023 01:19:36 +0000</pubDate><title>è¯„ä¼°ä¿æŠ¤çš„å…ç–«ç›¸å…³æ€§çš„å—æ§æ•ˆåº”æ–¹æ³•</title><link/>https://academic.oup.com/biostatistics/article/24/4/850/7320953?searchresult=1 <description><![CDATA[An immune correlate of risk (CoR) is an immunologic biomarker in vaccine recipients associated with an infectious disease clinical endpoint. An immune correlate of protection (CoP) is a CoR that can be used to reliably predict vaccine efficacy (VE) against the clinical endpoint and hence is accepted as a surrogate endpoint ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> 1b3ad46128587fe55a9f806994483be3</guid><pubDate> Wed, 18 Oct 2023 01:11:26 +0000</pubDate><title>çµæ´»çš„å‚æ•°åŠ é€Ÿå¤±æ•ˆæ—¶é—´æ¨¡å‹ä»¥åŠæ—¶é—´ç›¸å…³åŠ é€Ÿçš„æ‰©å±•...</title><link/> https://academic.oup.com/biostatistics/article/24/3/811/6593847?searchresult=1 <description><![CDATA[Accelerated failure time (AFT) models are used widely in medical research, though to a much lesser extent than proportional hazards models. In an AFT model, the effect of covariates act to accelerate or decelerate the time to event of interest, that is, shorten or extend the time to event. Commonly used parametric AFT ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> c29878990976b4c88c66872bd58e79c8</guid><pubDate> Wed, 18 Oct 2023 01:11:23 +0000</pubDate><title>ç–«è‹—åœ¨æŸä¸ªæ—¶é—´ç‚¹çš„åŠŸæ•ˆ</title><link/>https://academic.oup.com/biostatistics/article/24/3/603/6549823?searchresult=1 <description><![CDATA[Vaccine trials are generally designed to assess efficacy on clinical disease. The vaccine effect on infection, while important both as a proxy for transmission and to describe a vaccineâ€™s entire effects, requires frequent (e.g., twice a week) longitudinal sampling to capture all infections. Such sampling may not always be ...

    <br/><p><a target="_blank" href="https://www.amazon.com?&_encoding=UTF8&tag=stephen0f0-20&linkCode=ur2&linkId=307b0e9b43b3e9ab96d7dfa969645cdc&camp=1789&creative=9325">ğŸ›ï¸ æƒ³è¦åœ¨äºšé©¬é€Šè´­ç‰©å—ï¼Ÿå•å‡»æ­¤é“¾æ¥æ”¯æŒ RssEverythingï¼æ‚¨çš„è´­ä¹°å¯¹æˆ‘ä»¬æ¥è¯´æ„å‘³ç€æ•´ä¸ªä¸–ç•Œã€‚æ„Ÿè°¢æ‚¨çš„æ”¯æŒï¼ ğŸš€ğŸ‰</a> <img src="https://rsseverything.com/pixel/track?feed_id=9430&item_title=Vaccine efficacy at a point in time" width="0" height="0" style="display:none"></p><p> <sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> bb249b337f02a4bb89bd6840dcecbacf</guid><pubDate> Wed, 18 Oct 2023 01:11:18 +0000</pubDate><title>ç”¨äºä»å•ç»†èƒ RNA-seq æ•°æ®æ³¨é‡Šç»†èƒç±»å‹çš„æ¦‚ç‡åŸºå› è¡¨è¾¾æ¡å½¢ç </title><link/>https://academic.oup.com/biostatistics/article/23/4/1150/6622011?searchresult=1 <description><![CDATA[Single-cell RNA sequencing (scRNA-seq) quantifies gene expression for individual cells in a sample, which allows distinct cell-type populations to be identified and characterized. An important step in many scRNA-seq analysis pipelines is the annotation of cells into known cell types. While this can be achieved using ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> 3e4dd3ae1a7c49ad25c14e88da8bb263</guid><pubDate> Thu, 28 Dec 2023 08:19:50 +0000</pubDate><title> DeLIVRï¼šä¸€ç§ IV å›å½’çš„æ·±åº¦å­¦ä¹ æ–¹æ³•ï¼Œç”¨äºæµ‹è¯•è½¬å½•ä¸­çš„éçº¿æ€§å› æœæ•ˆåº”......</title><link/> https://academic.oup.com/biostatistics/advance-article/doi/10.1093/biostatistics/kxac051/6968926?searchresult=1 <description><![CDATA[Transcriptome-wide association studies (TWAS) have been increasingly applied to identify (putative) causal genes for complex traits and diseases. TWAS can be regarded as a two-sample two-stage least squares method for instrumental variable (IV) regression for causal inference. The standard TWAS (called TWAS-L) only ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> d6a95a21a6bfd464bb4df42df7677006</guid><pubDate> Sat, 30 Dec 2023 01:10:49 +0000</pubDate><title>ä½¿ç”¨è´å¶æ–¯ç–¾ç—…æ˜ å°„è¿›è¡Œå¤šç§ç»“æœçš„ç©ºé—´å·®å¼‚è¾¹ç•Œæ£€æµ‹</title><link/>https://academic.oup.com/biostatistics/article/24/4/922/6600528?searchresult=1 <description><![CDATA[Regional aggregates of health outcomes over delineated administrative units (e.g., states, counties, and zip codes), or areal units, are widely used by epidemiologists to map mortality or incidence rates and capture geographic variation. To capture health disparities over regions, we seek â€œdifference boundariesâ€ that ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> da482a127e9ce985255e4d8c43440c78</guid><pubDate> Sat, 23 Dec 2023 08:18:52 +0000</pubDate><title>ä½¿ç”¨å…·æœ‰ I ç±»é”™è¯¯ç‡æ§åˆ¶çš„å†å²æ•°æ®çš„è´å¶æ–¯å¤šå…ƒæˆåŠŸæ¦‚ç‡</title><link/>https://academic.oup.com/biostatistics/article/24/1/17/6494536?searchresult=1 <description><![CDATA[In clinical trials, it is common to have multiple clinical outcomes (e.g., coprimary endpoints or a primary and multiple secondary endpoints). It is often desirable to establish efficacy in at least one of multiple clinical outcomes, which leads to a multiplicity problem. In the frequentist paradigm, the most popular ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> f12b8500c8a7676c49b70deda3451156</guid><pubDate> Wed, 27 Dec 2023 08:18:59 +0000</pubDate><title>ä½¿ç”¨æ‘˜è¦çº§åˆ«ä¿¡æ¯çš„åˆ†å¸ƒå¼ Cox æ¯”ä¾‹é£é™©å›å½’</title><link/>https://academic.oup.com/biostatistics/article/24/3/776/6534990?searchresult=1 <description><![CDATA[Individual-level data sharing across multiple sites can be infeasible due to privacy and logistical concerns. This article proposes a general distributed methodology to fit Cox proportional hazards models without sharing individual-level data in multi-site studies. We make inferences on the log hazard ratios based on an ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> b7f6f25c25d3a449b5d266cb1d0001d3</guid><pubDate> Sat, 30 Dec 2023 08:18:10 +0000</pubDate><title>ç”¨äºå¤šä¸ªç”Ÿç‰©ç›¸å…³æ•°æ®é›†è”åˆåˆ†è§£çš„ä¸¤é˜¶æ®µé“¾æ¥æˆåˆ†åˆ†æ...</title><link/> https://academic.oup.com/biostatistics/article/23/4/1200/6561796?searchresult=1 <description><![CDATA[Integrative analysis of multiple data sets has the potential of fully leveraging the vast amount of high throughput biological data being generated. In particular such analysis will be powerful in making inference from publicly available collections of genetic, transcriptomic and epigenetic data sets which are designed to ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item><item><guid ispermalink="false"> 64b68f4983e98891b2ed497581351fbc</guid><pubDate> Mon, 11 Dec 2023 20:18:07 +0000</pubDate><title>ä½¿ç”¨æ—¶é—´åºåˆ—è§‚å¯Ÿæ•°æ®è¿›è¡Œå› æœæ¨ç†çš„è´å¶æ–¯å¤šå…ƒå› å­åˆ†ææ¨¡å‹...</title><link/> https://academic.oup.com/biostatistics/advance-article/doi/10.1093/biostatistics/kxad030/7459857?searchresult=1 <description><![CDATA[Assessing the impact of an intervention by using time-series observational data on multiple units and outcomes is a frequent problem in many fields of scientific research. Here, we propose a novel Bayesian multivariate factor analysis model for estimating intervention effects in such settings and develop an efficient ...

    <br/><p><sub><i>-- ç”±<a href="https://rsseverything.com">RssEverything</a>æœåŠ¡æä¾›</i></sub></p>]]>;</description></item></channel></rss>